Global Nucleic Acid Delivery Excipients Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nucleic Acid Delivery Excipients Market Research Report 2024
Nucleic acids, including plasmid DNA, oligonucleotides, small interfering RNA, messenger RNA and micro RNA provide significant promise in the treatment of challenging diseases. Unfortunately, their delivery as therapeutic agents has been a challenge. Nanoparticulate delivery systems, in which cationic lipids or polymers condense nucleic acids to form “lipoplex” or “polyplex” via the negative phosphate groups of nucleic acids show high productivity and loading efficiency. The intracellular delivery of these complexes is believed to occur via endocytosis followed by endosomal escape into the cytoplasm.
According to Mr Accuracy reports’s new survey, global Nucleic Acid Delivery Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery Excipients market research.
Key manufacturers engaged in the Nucleic Acid Delivery Excipients industry include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nucleic Acid Delivery Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery Excipients market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nucleic Acid Delivery Excipients report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Nucleic Acid Delivery Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery Excipients market research.
Key manufacturers engaged in the Nucleic Acid Delivery Excipients industry include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nucleic Acid Delivery Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery Excipients market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Segment by Application
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nucleic Acid Delivery Excipients report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices